A New Regulatory Function for E-Prescriptions: Linking the FDA to Physicians and Patient Records

14 Pages Posted: 22 Jun 2013 Last revised: 24 Feb 2014

See all articles by Andrew English

Andrew English

Harvard Law School

David Rosenberg

Harvard Law School

Huaou Yan

Harvard Law School

Date Written: June 19, 2013

Abstract

Despite recent improvements in FDA regulation of medical product usage, the Agency still lacks the capacity for directly and immediately sending physicians updated warnings and other advisories and for continuously overseeing their treatment decisions and outcomes. We propose deploying electronic prescription technology to fill this major regulatory gap. Although this technology has received extensive expert and funding support for its ability to better perform the time-honored functions of paper prescriptions, we are the first to consider its use to further FDA regulatory objectives. We make the case that by interfacing the FDA with physicians and computerized patient records, e-prescriptions can greatly improve the Agency’s capacity to inform, guide, and monitor medical product usage. Designed to operate in a check-off format, e-prescriptions would not only provide physicians with salient risk and efficacy alerts, best-practice protocols, and links to studies, but also query and specifically document their reasons for choosing off-label or contraindicated uses. In addition, by automatically requesting reports from physicians and retrieving information from computerized patient records, e-prescription technology can supply the FDA with comprehensive, systematic, and real time data on medical product outcomes, favorable as well as unfavorable. We assess these benefits against the costs of our proposal, including the extent to which a well-designed system would burden physician decisionmaking and expose patients to unnecessary and abusive surveillance of their medical records and treatments.

JEL Classification: K00, K13, K23, K32, I10, I18

Suggested Citation

English, Andrew and Rosenberg, Michael and Yan, Huaou, A New Regulatory Function for E-Prescriptions: Linking the FDA to Physicians and Patient Records (June 19, 2013). Harvard Public Law Working Paper No. 13-44, Available at SSRN: https://ssrn.com/abstract=2282701 or http://dx.doi.org/10.2139/ssrn.2282701

Andrew English

Harvard Law School ( email )

1563 Massachusetts Ave
Cambridge, MA 02138
United States

Michael Rosenberg (Contact Author)

Harvard Law School ( email )

1575 Massachusetts
Hauser 406
Cambridge, MA 02138
United States
617-496-4558 (Phone)
617-495-1110 (Fax)

Huaou Yan

Harvard Law School ( email )

1563 Massachusetts Ave
Cambridge, MA 02138
United States

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
53
Abstract Views
872
rank
520,729
PlumX Metrics